IG 302 Pill - white round
Pill with imprint IG 302 is White, Round and has been identified as Alfuzosin Hydrochloride Extended-Release 10 mg. It is supplied by Cipla USA, Inc.
Alfuzosin is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 302
Alfuzosin Hydrochloride Extended-Release
- Imprint
- IG 302
- Strength
- 10 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 69097-0844
- Inactive Ingredients
-
microcrystalline cellulose,
guar gum,
hypromelloses,
silicon dioxide,
magnesium stearate
Note: Inactive ingredients may vary.
More about alfuzosin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (78)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alpha-adrenoreceptor antagonists
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.